-
. The project is one of four strategic initiatives funded by the Faculty of Humanities, University of Oslo, 2024‒2028. The main aim of the project is to discuss how humans affectively deal with environmental
-
of Humanities, University of Oslo, 2024‒2028. The main aim of the project is to discuss how humans affectively deal with environmental change, as represented in and through literature, from the past and today, in
-
funded by the Faculty of Humanities, University of Oslo, 2024‒2028. The main aim of the project is to discuss how humans affectively deal with environmental change, as represented in and through literature
-
the Norwegian Centre of Excellence Hybrid-technology-hub (HTH). Colourbox via Unsplash Colourbox More about the position NoPSC is dedicated to research on the chronic liver disease primary sclerosing
-
dedicated to research on the chronic liver disease primary sclerosing cholangitis (PSC), for which affected individuals have a 20% lifetime risk of bile duct cancer. There is currently no effective treatment
-
-dimensional immune profiling by flow cytometry, single-cell indexed FACS-sorting and RNA sequencing. Additionally, viral transduction and CRISRP/Cas9 will be used to genetically engineer primary NK cells, NK
-
NoPSC and the Norwegian Centre of Excellence Hybrid-technology-hub (HTH). Colourbox via Unsplash Colourbox More about the position NoPSC is dedicated to research on the chronic liver disease primary
-
to genetically engineer primary NK cells, NK cell lines and/or iPSC-derived NK cells. 3D killing assays will be implemented to monitor and evaluate the function of the engineered NK cells, such as cytotoxicity
-
period of up to three years. The main purpose of the fellowship is to qualify researchers for work in higher academic positions within their disciplines. The candidate We seek a highly motivated, result
-
at OUS. An overarching theme of our research is to model tumor heterogeneity and its clinical impact based on DNA/RNA sequencing of multiple tissue samples from primary and metastatic tumors. We also have